Possis Delays New Vascular Graft Launch; May Sell Off Entire Division
This article was originally published in The Gray Sheet
Executive Summary
Possis is shelving plans to market its newly approved Perma-Seal silicon elastomer access graft pending a strategic review of the firm's entire vascular graft division by Salomon Smith Barney due Nov. 1.